We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App




Critical Care Analyzer with Micro Capillary Sample Mode Provides Major Blood-Saving Benefit

By LabMedica International staff writers
Posted on 05 Oct 2023
Print article
Image: FDA has cleared the Stat Profile Prime Plus analyzer for micro capillary sample mode (Photo courtesy of Nova Biomedical)
Image: FDA has cleared the Stat Profile Prime Plus analyzer for micro capillary sample mode (Photo courtesy of Nova Biomedical)

Excessive blood collection for lab tests in critically ill patients is known to be a significant cause of severe anemia and increased use of blood products. This, in turn, leads to longer hospital stays and higher mortality rates. Now, a novel blood gas analyzer featuring a micro capillary sample mode provides a major blood-saving benefit for the diagnostic testing of critically ill patients.

Nova Biomedical (Waltham, MA, USA) has received the U.S. Food and Drug Administration (FDA) 510(k) clearance for a micro capillary sample mode on its Stat Profile Prime Plus Critical Care analyzer. This new feature allows Prime Plus to perform an 11-test panel using only 90 microliters of capillary blood. Alternatively, a comprehensive 22-test profile can be done with just 135 microliters of blood. This sampling mode enhances Prime Plus's existing capabilities for conserving blood during diagnostic testing and is now a standard feature on all Prime Plus analyzers.

The Stat Profile Prime Plus boasts a state-of-the-art test menu for critical care, featuring a range of tests including pH, PCO2, PO2, SO2%, Na, K, iCa, iMg, Cl, TCO2, glucose, lactate, creatinine, urea, hematocrit, hemoglobin, MCHC, estimated plasma volume, CO-Oximetry panel, and 34 calculated results. The simple, compact analyzer uses maintenance-free, replaceable cartridges for sensors and reagents, along with patented, maintenance-free, whole blood CO-Oximetry technology. The device's ability to use small-volume microcapillary blood collection tubes eliminates sample over-draws, dead volume, and waste typically associated with syringe or vacuum tube methods. Moreover, Prime Plus allows for scheduled bundling of tests, reducing the number of times blood needs to be drawn as well as the variety of containers used, thereby minimizing blood drawn for critical care testing.

"Prime Plus microsample volume and comprehensive test menu provide a major blood-saving benefit for diagnostic testing of critically ill patients,” said Terry Austin, Sales Product Line Manager for Prime Plus analyzer. “Prime Plus delivers gases, electrolytes, glucose, lactate, hematocrit, or any subset of these tests on just two drops (90 microliters) of blood. A basic metabolic panel of electrolytes, glucose, lactate, creatinine, urea, and hematocrit is available on 135 microliters, 1/50th the volume of blood needed for the same tests in the central laboratory."

Related Links:
Nova Biomedical

New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Unit-Dose Packaging solution
HLX
New
Cooling Table Centrifuge
MPW-352R
New
Hemacytometer Cover Glasses
Propper Hemacytometer Cover Glasses

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: Last year, Seegene and Werfen has entered into a collaboration on the OneSystem business to develop syndromic qPCR assays (Photo courtesy of Seegene)

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

Seegene (Seoul, South Korea), a leading PCR molecular diagnostics company, and Werfen (Barcelona, Spain), a global diagnostics specialist, have finalized a partnership agreement as part of a technology-sharing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.